nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—hypertension—focal segmental glomerulosclerosis	0.4	1	CtDrD
Captopril—MMP2—focal segmental glomerulosclerosis	0.183	0.437	CbGaD
Captopril—MMP9—focal segmental glomerulosclerosis	0.12	0.288	CbGaD
Captopril—ACE—focal segmental glomerulosclerosis	0.0816	0.195	CbGaD
Captopril—ALB—focal segmental glomerulosclerosis	0.0334	0.08	CbGaD
Captopril—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0326	0.536	CbGbCtD
Captopril—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.239	CbGbCtD
Captopril—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.225	CbGbCtD
Captopril—REN—arteriole—focal segmental glomerulosclerosis	0.0121	0.233	CbGeAlD
Captopril—REN—nephron—focal segmental glomerulosclerosis	0.00525	0.101	CbGeAlD
Captopril—ACE—arteriole—focal segmental glomerulosclerosis	0.00514	0.0994	CbGeAlD
Captopril—MMP2—nephron—focal segmental glomerulosclerosis	0.00482	0.0933	CbGeAlD
Captopril—MMP2—endothelium—focal segmental glomerulosclerosis	0.00227	0.044	CbGeAlD
Captopril—ACE—nephron—focal segmental glomerulosclerosis	0.00224	0.0432	CbGeAlD
Captopril—MMP9—endothelium—focal segmental glomerulosclerosis	0.00198	0.0382	CbGeAlD
Captopril—F2—endothelium—focal segmental glomerulosclerosis	0.00173	0.0334	CbGeAlD
Captopril—LTA4H—nephron tubule—focal segmental glomerulosclerosis	0.00147	0.0284	CbGeAlD
Captopril—LTA4H—kidney—focal segmental glomerulosclerosis	0.00129	0.0249	CbGeAlD
Captopril—LTA4H—cortex of kidney—focal segmental glomerulosclerosis	0.00126	0.0243	CbGeAlD
Captopril—REN—nephron tubule—focal segmental glomerulosclerosis	0.00113	0.0219	CbGeAlD
Captopril—Enalapril—ACE—focal segmental glomerulosclerosis	0.00106	1	CrCbGaD
Captopril—ACE—endothelium—focal segmental glomerulosclerosis	0.00105	0.0204	CbGeAlD
Captopril—REN—kidney—focal segmental glomerulosclerosis	0.000996	0.0193	CbGeAlD
Captopril—REN—cortex of kidney—focal segmental glomerulosclerosis	0.00097	0.0188	CbGeAlD
Captopril—MMP2—kidney—focal segmental glomerulosclerosis	0.000915	0.0177	CbGeAlD
Captopril—MMP2—cortex of kidney—focal segmental glomerulosclerosis	0.000891	0.0172	CbGeAlD
Captopril—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.0753	CcSEcCtD
Captopril—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.000809	0.0156	CbGeAlD
Captopril—MMP9—kidney—focal segmental glomerulosclerosis	0.000796	0.0154	CbGeAlD
Captopril—F2—kidney—focal segmental glomerulosclerosis	0.000695	0.0134	CbGeAlD
Captopril—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.000693	0.0134	CbGeAlD
Captopril—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.000673	0.013	CbGeAlD
Captopril—SLC15A1—kidney—focal segmental glomerulosclerosis	0.000592	0.0114	CbGeAlD
Captopril—ACE—nephron tubule—focal segmental glomerulosclerosis	0.000483	0.00934	CbGeAlD
Captopril—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000466	0.0419	CcSEcCtD
Captopril—ACE—kidney—focal segmental glomerulosclerosis	0.000424	0.0082	CbGeAlD
Captopril—ACE—cortex of kidney—focal segmental glomerulosclerosis	0.000413	0.00799	CbGeAlD
Captopril—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.0369	CcSEcCtD
Captopril—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.0333	CcSEcCtD
Captopril—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.0304	CcSEcCtD
Captopril—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.028	CcSEcCtD
Captopril—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.0275	CcSEcCtD
Captopril—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000282	0.0253	CcSEcCtD
Captopril—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.0251	CcSEcCtD
Captopril—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000265	0.0239	CcSEcCtD
Captopril—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.0234	CcSEcCtD
Captopril—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.0232	CcSEcCtD
Captopril—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.0213	CcSEcCtD
Captopril—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.021	CcSEcCtD
Captopril—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000208	0.00402	CbGeAlD
Captopril—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.0179	CcSEcCtD
Captopril—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.0173	CcSEcCtD
Captopril—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.0172	CcSEcCtD
Captopril—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.0162	CcSEcCtD
Captopril—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.0159	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000176	0.00306	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—SPP1—focal segmental glomerulosclerosis	0.000175	0.00305	CbGpPWpGaD
Captopril—F2—Platelet Aggregation (Plug Formation)—FN1—focal segmental glomerulosclerosis	0.000175	0.00305	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000173	0.00301	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000172	0.003	CbGpPWpGaD
Captopril—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.0154	CcSEcCtD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—focal segmental glomerulosclerosis	0.000171	0.00297	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.00017	0.00297	CbGpPWpGaD
Captopril—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00017	0.00329	CbGeAlD
Captopril—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.0153	CcSEcCtD
Captopril—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.0153	CcSEcCtD
Captopril—MMP2—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000167	0.0029	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000166	0.00289	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000159	0.00277	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—MMP9—focal segmental glomerulosclerosis	0.000158	0.00275	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000157	0.00274	CbGpPWpGaD
Captopril—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000157	0.0141	CcSEcCtD
Captopril—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000157	0.0141	CcSEcCtD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—focal segmental glomerulosclerosis	0.000156	0.00272	CbGpPWpGaD
Captopril—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.014	CcSEcCtD
Captopril—MMP2—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000153	0.00267	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000152	0.00266	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.00015	0.00261	CbGpPWpGaD
Captopril—ABCB1—kidney—focal segmental glomerulosclerosis	0.000149	0.00289	CbGeAlD
Captopril—MMP9—AP-1 transcription factor network—AGT—focal segmental glomerulosclerosis	0.000147	0.00257	CbGpPWpGaD
Captopril—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000145	0.00281	CbGeAlD
Captopril—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.0131	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—SPP1—focal segmental glomerulosclerosis	0.000143	0.00249	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000142	0.00248	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.000141	0.00246	CbGpPWpGaD
Captopril—MMP9—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000141	0.00245	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000141	0.00245	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.00014	0.00244	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000139	0.00242	CbGpPWpGaD
Captopril—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.0124	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.000138	0.0024	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000136	0.00237	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000135	0.00235	CbGpPWpGaD
Captopril—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.012	CcSEcCtD
Captopril—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.012	CcSEcCtD
Captopril—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000132	0.0119	CcSEcCtD
Captopril—MMP9—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000129	0.00225	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000129	0.00224	CbGpPWpGaD
Captopril—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000128	0.0115	CcSEcCtD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.000127	0.00221	CbGpPWpGaD
Captopril—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.0114	CcSEcCtD
Captopril—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.0113	CcSEcCtD
Captopril—F2—Syndecan-4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	0.000125	0.00218	CbGpPWpGaD
Captopril—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000124	0.0112	CcSEcCtD
Captopril—MMP9—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000124	0.00216	CbGpPWpGaD
Captopril—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000123	0.0111	CcSEcCtD
Captopril—MMP2—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000123	0.00214	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000121	0.00211	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000119	0.00208	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000119	0.00207	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.000119	0.00207	CbGpPWpGaD
Captopril—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.0107	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	0.000117	0.00203	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000117	0.00203	CbGpPWpGaD
Captopril—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0104	CcSEcCtD
Captopril—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0104	CcSEcCtD
Captopril—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0104	CcSEcCtD
Captopril—REN—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000115	0.00201	CbGpPWpGaD
Captopril—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000115	0.0103	CcSEcCtD
Captopril—MMP2—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000113	0.00198	CbGpPWpGaD
Captopril—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000113	0.0102	CcSEcCtD
Captopril—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000113	0.00197	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000113	0.00196	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.000113	0.00196	CbGpPWpGaD
Captopril—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.0101	CcSEcCtD
Captopril—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000111	0.01	CcSEcCtD
Captopril—MMP9—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000109	0.0019	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000109	0.0019	CbGpPWpGaD
Captopril—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.00979	CcSEcCtD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—focal segmental glomerulosclerosis	0.000108	0.00188	CbGpPWpGaD
Captopril—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00953	CcSEcCtD
Captopril—MMP2—EPH-Ephrin signaling—MMP9—focal segmental glomerulosclerosis	0.000105	0.00182	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000104	0.00182	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000104	0.00181	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.000104	0.00181	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000102	0.00178	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.00911	CcSEcCtD
Captopril—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000101	0.00905	CcSEcCtD
Captopril—MMP9—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.0001	0.00175	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—SERPINE1—focal segmental glomerulosclerosis	0.0001	0.00175	CbGpPWpGaD
Captopril—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	9.98e-05	0.00898	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	9.92e-05	0.00173	CbGpPWpGaD
Captopril—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	9.91e-05	0.00892	CcSEcCtD
Captopril—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	9.89e-05	0.00889	CcSEcCtD
Captopril—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	9.79e-05	0.0088	CcSEcCtD
Captopril—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	9.67e-05	0.00869	CcSEcCtD
Captopril—F2—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	9.64e-05	0.00168	CbGpPWpGaD
Captopril—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	9.59e-05	0.00862	CcSEcCtD
Captopril—MMP9—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	9.53e-05	0.00166	CbGpPWpGaD
Captopril—Constipation—Cyclosporine—focal segmental glomerulosclerosis	9.51e-05	0.00855	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	9.46e-05	0.00165	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	9.24e-05	0.00161	CbGpPWpGaD
Captopril—F2—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	9.17e-05	0.0016	CbGpPWpGaD
Captopril—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	9.16e-05	0.00824	CcSEcCtD
Captopril—F2—Folate Metabolism—ALB—focal segmental glomerulosclerosis	9.15e-05	0.00159	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	9.12e-05	0.00159	CbGpPWpGaD
Captopril—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	9.09e-05	0.00818	CcSEcCtD
Captopril—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	9.09e-05	0.00158	CbGpPWpGaD
Captopril—F2—Hemostasis—ACTN4—focal segmental glomerulosclerosis	9.06e-05	0.00158	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	8.86e-05	0.00154	CbGpPWpGaD
Captopril—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	8.79e-05	0.00791	CcSEcCtD
Captopril—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	8.79e-05	0.00791	CcSEcCtD
Captopril—MMP2—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	8.75e-05	0.00152	CbGpPWpGaD
Captopril—LTA4H—Metabolism—LIPC—focal segmental glomerulosclerosis	8.71e-05	0.00152	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	8.62e-05	0.0015	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	8.6e-05	0.0015	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	8.43e-05	0.00147	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	8.06e-05	0.0014	CbGpPWpGaD
Captopril—MMP9—Axon guidance—TRPC6—focal segmental glomerulosclerosis	8.04e-05	0.0014	CbGpPWpGaD
Captopril—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	7.98e-05	0.00718	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	7.97e-05	0.00139	CbGpPWpGaD
Captopril—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	7.87e-05	0.00708	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.84e-05	0.00136	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	7.8e-05	0.00136	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—TGFB1—focal segmental glomerulosclerosis	7.69e-05	0.00134	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CTGF—focal segmental glomerulosclerosis	7.67e-05	0.00134	CbGpPWpGaD
Captopril—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	7.61e-05	0.00684	CcSEcCtD
Captopril—MMP9—Developmental Biology—MYH9—focal segmental glomerulosclerosis	7.44e-05	0.0013	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	7.37e-05	0.00128	CbGpPWpGaD
Captopril—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	7.35e-05	0.00661	CcSEcCtD
Captopril—REN—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	7.31e-05	0.00127	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	7.29e-05	0.00127	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	7.28e-05	0.00127	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	7.27e-05	0.00127	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	7.21e-05	0.00126	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	7.18e-05	0.00125	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	7.15e-05	0.00125	CbGpPWpGaD
Captopril—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	7.07e-05	0.00636	CcSEcCtD
Captopril—LTA4H—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.07e-05	0.00123	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	7.05e-05	0.00123	CbGpPWpGaD
Captopril—Rash—Cyclosporine—focal segmental glomerulosclerosis	7.01e-05	0.00631	CcSEcCtD
Captopril—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	7e-05	0.0063	CcSEcCtD
Captopril—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	6.97e-05	0.00121	CbGpPWpGaD
Captopril—Headache—Cyclosporine—focal segmental glomerulosclerosis	6.97e-05	0.00627	CcSEcCtD
Captopril—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	6.91e-05	0.0012	CbGpPWpGaD
Captopril—Nausea—Cyclosporine—focal segmental glomerulosclerosis	6.6e-05	0.00594	CcSEcCtD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	6.59e-05	0.00115	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	6.35e-05	0.00111	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	6.25e-05	0.00109	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	6.17e-05	0.00107	CbGpPWpGaD
Captopril—F2—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	6.06e-05	0.00106	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	5.97e-05	0.00104	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	5.77e-05	0.001	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	5.75e-05	0.001	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	5.74e-05	0.001	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	5.73e-05	0.000998	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	5.73e-05	0.000998	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	5.64e-05	0.000983	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	5.59e-05	0.000973	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—LPL—focal segmental glomerulosclerosis	5.5e-05	0.000958	CbGpPWpGaD
Captopril—LTA4H—Metabolism—LPL—focal segmental glomerulosclerosis	5.32e-05	0.000926	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	5.19e-05	0.000903	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	5.12e-05	0.000892	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	5.1e-05	0.000889	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	5e-05	0.00087	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	4.88e-05	0.00085	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	4.83e-05	0.000842	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	4.71e-05	0.000821	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	4.71e-05	0.00082	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	4.64e-05	0.000808	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	4.58e-05	0.000797	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AGT—focal segmental glomerulosclerosis	4.55e-05	0.000792	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	4.47e-05	0.000779	CbGpPWpGaD
Captopril—F2—Hemostasis—TRPC6—focal segmental glomerulosclerosis	4.35e-05	0.000757	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	4.28e-05	0.000745	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	4.19e-05	0.00073	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	4.14e-05	0.000721	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	3.99e-05	0.000696	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	3.92e-05	0.000683	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MMP9—focal segmental glomerulosclerosis	3.88e-05	0.000677	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.87e-05	0.000674	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	3.81e-05	0.000663	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	3.79e-05	0.00066	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	3.77e-05	0.000657	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	3.75e-05	0.000653	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	3.72e-05	0.000647	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	3.64e-05	0.000634	CbGpPWpGaD
Captopril—F2—Hemostasis—GNAQ—focal segmental glomerulosclerosis	3.63e-05	0.000633	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	3.63e-05	0.000633	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—LPL—focal segmental glomerulosclerosis	3.61e-05	0.000629	CbGpPWpGaD
Captopril—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	3.59e-05	0.000626	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	3.57e-05	0.000622	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—focal segmental glomerulosclerosis	3.49e-05	0.000608	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	3.49e-05	0.000608	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	3.48e-05	0.000606	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	3.43e-05	0.000598	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MMP2—focal segmental glomerulosclerosis	3.39e-05	0.00059	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	3.35e-05	0.000583	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	3.34e-05	0.000582	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	3.27e-05	0.000569	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.19e-05	0.000555	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	3.15e-05	0.000549	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.14e-05	0.000548	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	3.12e-05	0.000543	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.07e-05	0.000535	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	2.97e-05	0.000518	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	2.9e-05	0.000505	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	2.89e-05	0.000504	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.87e-05	0.0005	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	2.8e-05	0.000487	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.77e-05	0.000483	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.75e-05	0.000478	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.73e-05	0.000476	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.61e-05	0.000455	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.6e-05	0.000452	CbGpPWpGaD
Captopril—F2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.58e-05	0.000449	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.56e-05	0.000446	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2.49e-05	0.000434	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	2.48e-05	0.000432	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	2.47e-05	0.000431	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MMP2—focal segmental glomerulosclerosis	2.42e-05	0.000421	CbGpPWpGaD
Captopril—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	2.41e-05	0.000419	CbGpPWpGaD
Captopril—F2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.37e-05	0.000413	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.33e-05	0.000406	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	2.3e-05	0.0004	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	2.28e-05	0.000398	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.2e-05	0.000384	CbGpPWpGaD
Captopril—F2—Hemostasis—FN1—focal segmental glomerulosclerosis	2.16e-05	0.000376	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.14e-05	0.000372	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	2.1e-05	0.000366	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	2.09e-05	0.000363	CbGpPWpGaD
Captopril—F2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2e-05	0.000349	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	1.97e-05	0.000343	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.93e-05	0.000335	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.91e-05	0.000332	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	1.91e-05	0.000332	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.9e-05	0.000331	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	1.88e-05	0.000327	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	1.84e-05	0.00032	CbGpPWpGaD
Captopril—F2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.8e-05	0.000313	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—focal segmental glomerulosclerosis	1.79e-05	0.000313	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.78e-05	0.00031	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.74e-05	0.000304	CbGpPWpGaD
Captopril—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	1.72e-05	0.0003	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	1.66e-05	0.00029	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.62e-05	0.000282	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.62e-05	0.000282	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.6e-05	0.000278	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.6e-05	0.000278	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.5e-05	0.000261	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.49e-05	0.00026	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.48e-05	0.000257	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.47e-05	0.000257	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.47e-05	0.000255	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.46e-05	0.000254	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	1.44e-05	0.000251	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	1.44e-05	0.000251	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.42e-05	0.000248	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	1.38e-05	0.000241	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.34e-05	0.000234	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.31e-05	0.000228	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.24e-05	0.000215	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.23e-05	0.000215	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.2e-05	0.000209	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.19e-05	0.000207	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.14e-05	0.000198	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.14e-05	0.000198	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.13e-05	0.000196	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.03e-05	0.000179	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.87e-06	0.000172	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.55e-06	0.000166	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.49e-06	0.000165	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.27e-06	0.000161	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.78e-06	0.000153	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	8.74e-06	0.000152	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.6e-06	0.00015	CbGpPWpGaD
Captopril—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	8.57e-06	0.000149	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	8.47e-06	0.000148	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.45e-06	0.000147	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.93e-06	0.000138	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.89e-06	0.000138	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.33e-06	0.000128	CbGpPWpGaD
Captopril—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	7.21e-06	0.000126	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	7.13e-06	0.000124	CbGpPWpGaD
Captopril—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	6.34e-06	0.00011	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.31e-06	0.00011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.1e-06	0.000106	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	5.95e-06	0.000104	CbGpPWpGaD
Captopril—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.84e-06	0.000102	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.56e-06	9.68e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.4e-06	9.41e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.24e-06	9.12e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.12e-06	8.92e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.98e-06	8.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.83e-06	8.41e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.67e-06	8.13e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.5e-06	7.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	4.4e-06	7.66e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	3.85e-06	6.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.85e-06	6.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	3.76e-06	6.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	3.63e-06	6.32e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.3e-06	5.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.11e-06	5.41e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.53e-06	4.41e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.38e-06	4.15e-05	CbGpPWpGaD
